Zatosetron maleate is a potent, selective
5-hydroxytryptamine
receptor antagonist. In anticipation of commercialization,
a
manufacturing synthesis of zatosetron from tropinone and
5-chlorosalicylic acid was developed. Development
efforts
focused on addressing several key issues including the
supply
and quality of the critical raw material tropinone,
improvements
in the stereoselective formation of 3-endo-tropanamine, and
the
compatibility with existing manufacturing capabilities of
process
requirements for the Claisen rearrangement used to produce
a crucial benzofuran intermediate. The results of these
studies
and an improved route to zatosetron maleate are described.